News Results
There are 989,865 News Results
May 30, 2018
Windtree Therapeutics' Aerosolized KL4 Surfactant Preclinical Data in Influenza Presented at the 2018 American Thoracic Society Meeting
Jun 2, 2018
DETROIT, June 3, 2018 /PRNewswire/ -- The four Acura entries in this weekend's Detroit Grand Prix Presented by Lear completed a nearly perfect set of results in today's 100-minute race,...
Jun 5, 2018
WARROAD, Minn., June 5, 2018 /PRNewswire/ -- The Marvin Family of Brands is announcing the winners of its 10(th) Marvin Architects Challenge - an annual design competition that recognizes inventive...
Jun 11, 2018
SHANGHAI, June 11, 2018 /PRNewswire/ -- The Shanghai Dragons team is busy preparing for the second Shanghai Dragon's Team day event at Blizzard Arena in Burbank, California. Under the warm...
Jun 18, 2018
SAN DIEGO, June 18, 2018 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the...
Jun 25, 2018
CAMBRIDGE, Mass., June 25, 2018 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK), a clinical-stage oncology company focused on biomarker-defined cancers, today announced top-line results from the CARRIE study, a randomized...
Jun 28, 2018
IRVINE, Calif., June 28, 2018 /PRNewswire/ -- Razer(TM), the leading global lifestyle brand for gamers, today announced the new Razer Huntsman premium gaming keyboard line. The duo includes a full-feature...
Jul 6, 2018
WASHINGTON, July 6, 2018 /PRNewswire-USNewswire/ -- https://www.cpsc.gov/Recalls/2018/Sandoz-and-Novartis-Recall-Prescription-Drug-Blister-Packages-Due-to-Failure-to-Meet-Child-Resistant-Closure-Requirements
Jul 9, 2018
BETHESDA, Md., July 9, 2018 /PRNewswire/ -- Lockheed Martin (NYSE: LMT) will showcase its LM-100J Super Hercules commercial freighter at Farnborough International Airshow (FIA) 2018, held in Farnborough, England, July...
Jul 16, 2018
NEW YORK, July 16, 2018 /PRNewswire/ -- Neurotrope Inc. (NASDAQ: NTRP) a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), is announcing that the first...
